Do you need to talk to a Depakote lawsuit attorney? Contact Williams Hart today - 800-761-3187.

FDA approved generic Depakote for US market

An India-based manufacturer of generic Depakote ER was recently approved by the U.S. Food and Drug Administration (USFDA) to market the mental illness drug in America, VCCircle reported on June 3.

In a statement, Aurobindo Pharma Ltd. said the USFDA gave them permission to make and sell Divalproex Sodium, a generic version of Depakote ER in the United States. The federal agency allowed the firm to produce 250mg and 500mg tablets.  The Depakote substitue had an estimated market size of $690 million within the past year. The USFDA have approved nearly 200 additional abbreviated drug applications for Aurobindo.

Unfortunately, pregnant woman who take Divalproex Sodium or Depakote risk their babies being born with dangerous birth defects. If this has happened to you or a loved one, the attorneys of Williams Hart may represent you to pursue damages from negligent drug manufacturers. Tell us your situation today at 800-761-3187, and learn about your legal options.

Tagged , , | Leave a comment

Contact Williams Hart

By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.





home  |  about us  |  attorneys  |  depakote  |  birth defects  |  other side effects  |  faqs  |  articles  |  legal resources  |  contact us  |  press  |  blog  |  Log in
Copyright ©2007-2010 Williams Hart. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Hart's primary office is located in Texas. Terms of Use. Disclaimer. Sitemap.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-761-3187